Description

 This comprehensive three-day conference focuses on new research, diagnostic best practices, innovative treatments, and their practical clinical applications across the spectrum of child and adolescent psychiatric disorders – ADHD, autism, depression, eating disorders, OCD, psychosis, substance abuse, Tourette’s, and much more.

The diagnosis of mental disorders in children is challenging, considering many signs and symptoms that could be interpreted as mental disorders – such as emotional outbursts, mood swings, strange eating habits, shyness, and nervousness – could also be a part of normal child development. The frequent presence of co-morbidities in children also makes differential diagnosis and selection of optimal treatment strategies difficult. During this conference, take advantage of personal access to globally-recognized faculty, ask your most pressing clinical questions about diagnostic tools and treatment strategies, and leave with guidance and solutions to the challenges you face in clinical practice.

The conference is led by more than two dozen expert faculty from the Massachusetts General Hospital Department of Psychiatry, and includes Curbside Consultation hours with faculty experts, evening sessions on hot topics, and day-long opportunities to engage and exchange ideas with both faculty and other participants.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
  • Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
  • Discuss the presentation diagnosis, and current treatment options available for depression, psychosis, manic depression and anxiety.
  • Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
  • Recognize the risk management issues associated with adolescent substance abuse and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.

Target Audience

This program is intended for psychiatrists, psychologists, pediatricians, physicians, psychiatric nurses, physician assistants, nurse practitioners, residents and fellows and social workers.

Pricing

MDs, EdDs, PsychDs, and PhDs:

Register before January 24, 2014: $665.00
Register after January 24, 2014: $765.00

Nurses, Counselors, Social Workers and all other care providers:

Register before January 24, 2014: $565.00
Register after January 24, 2014: $665.00

Cancellation Policy

A $100.00 administrative fee will be deducted for cancellations. Refund requests must be received in writing no later than March 7, 2014. No refunds or credits will be made thereafter.

Agenda

Friday, March 14, 2014
7:00-7:45 AM Continental Breakfast
7:00-7:45 Registration
7:45-8:00 Introduction ~ Course Directors: Joseph Biederman, MD; Thomas J. Spencer, MD; Timothy E. Wilens, MD
8:00-9:00 Diagnosis & Assessment in Pediatric Psychopharmacology ~ Joseph Biederman, MD
9:00-9:45 Developmental Psychopharmacology ~ Pradeep Bhide, MD
9:45-10:30 Implications of Psychiatric Genetics for Psychopharmacology ~ Roy H. Perlis, MD
10:30-10:45 Coffee Break
10:45-11:45 ADHD Across the Life Cycle ~ Joseph Biederman, MD
11:45-1:00 PM Lunch (On Your Own)
1:00-2:00 Pharmacologic Treatment of ADHD Across the Life Cycle: Stimulants ~ Thomas J. Spencer, MD
2:00-3:00 Pharmacologic Treatment of ADHD Across the Life Cycle: Non-Stimulants ~ Timothy E. Wilens, MD
3:00-3:15 Coffee Break
3:15-4:15** Adolescent Substance Abuse: From Diagnosis and Treatment to Risk Management and Medico Legal Concerns** ~ Timothy E. Wilens
4:15-5:15** Question and Answer including The Ethical and Safe On- and Off-Label Use of Psychotropics in Practice** ~ Moderator: Joseph Biederman, MD; Thomas J. Spencer, MD; Timothy E. Wilens, MD; Janet Wozniak, MD
5:15-6:30 Dinner (On Your Own)
Friday Evening Seminars Seminars run from 6:30-7:30pm
An NP’s View on the Management of Substance Abuse in Young Adults Cally Lilley, APRN-BC, NS                                                                                                       
Managing the Complex Adult with ADHD Craig Surman, MD                                

 

Saturday, March 15, 2014
7:30-8:00 AM Continental Breakfast
8:00-9:00 Juvenile Depression ~ Karen Wagner, MD, PhD
9:00-9:45 Juvenile Mania: Treatment ~ Janet Wozniak, MD
9:45-10:30 Differential Unipolar vs. Bipolar Mood Disorders in the Young ~ Mai Uchida, MD
10:30-10:45 Coffee Break
10:45-11:45 Managing First Episode Psychosis ~ Abigail Donovan, MD
11:45-1:00 PM Lunch Break (On Your Own)
1:00-2:00 Tourette's Disorder & Tics ~ Barbara Coffey, MD, MS
2:00-2:45 Treating Comorbidities in the Context of ASD (Autism Spectrum Disorders) ~ Gagan Joshi, MD
2:45-3:00 Coffee Break
3:00-4:00 Cognitive Behavioral Treatment in Pediatric Psychiatry ~ Aude Henin, PhD
4:00-5:00 Neuropsychological Testing ~ Ronna Fried, EdD
5:00-6:30 Dinner (On your own)

Saturday Evening Seminars 

6:30-7:30          Educational Connection ~ Ronna Fried, EdD
6:30-8:30                                                                                                                                                                                                                                                                                                                                         Violence and Risk Assessment in Clinical Practice (2-hour Interactive Roundtable)** ~ Joseph Biederman, MD, Ronald Schouten, MD, JD FBI Special Agent Thomas M. Dalton, FBI Supervisory Special Agent Robert C. Lewis , FBI Special Agent Brian R. Hoff. 

 

Sunday, March 16, 2014
7:30-8:00 AM Continental Breakfast
8:00-9:00 Pharmacology of Anxiety Disorders and OCD in Childhood and Adolescence ~ Daniel A. Geller, MD
9:00-10:00 Neuroimaging in Clinical Practice ~ John Gabrieli
10:00-10:15  Coffee Break
10:15-11:00 Eating Disorders ~ Kamryn Eddy, PhD
11:00-11:45 Pediatric Consultation Liason: Psychopharmacology in Clinical Practice ~ Annah Abrams, MD
11:45-12:45 PM Lunch (On your own)
12:45-1:45** Antidepressants and Suicide Risk and Prevention** ~ Jefferson B. Prince, PhD
1:45-2:45** Liability Prevention in Child and Adolescent Psychopharmacology** ~ Ronald Schouten, MD, JD
2:45 Adjourn

**Session eligible for Risk Management credit.

Faculty

  • Chief, Child Psychiatry Consultation Liaison Service, and Child Psychiatrist, Pediatric Hematology Oncology Unit, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Professor, Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience
    Director, Center for Brain Repair, Department of Biomedical Sciences, Florida State University College of Medicine
  • Director, Pediatric Psychopharmacology Unit, Massachusetts General Hospital
    Professor of Psychiatry, Harvard Medical School
  • Associate Professor, Department of Child and Adolescent Psychiatry, NYU School of Medicine
    Director, Tics and Tourette’s Clinical and Research Program, NYU Child Study Center; Research Psychiatrist, Nathan Kline Institute for Psychiatric Research
  • Director, First Episode and Early Psychosis Program
    Associate Director, Acute Psychiatry Service
    Massachusetts General Hospital
  • Co-Director, Eating Disorders Clinical and Research Program, Massachusetts General Hospital
    Assistant Professor Psychiatry, Harvard Medical School
  • Co-Director of Neuropsychology in the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Instructor in Psychology in the Department of Psychiatry, Harvard Medical School
  • Director, Pediatric OCD and Tic Disorder Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Co-Director, Child Cognitive-Behavioral Therapy Program, Massachusetts General Hospital
    Director, Cognitive Behavior Therapy Program, Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
  • Director, Autism Spectrum Disorders Program
    Clinical & Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Medical Director, Bipolar Clinic and Research Program, Massachusetts General Hospital
    Principal Investigator, Center for Human Genetic Research, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Director of Child Psychiatry, North Shore Medical Center
    Staff, Child Psychiatry and Pediatric Psychopharmacology Clinics, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Director, Law & Psychiatry Service, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Associate Chief of Psychiatry, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Scientific Coordinator, Adult ADHD Research Program, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Staff Psychiatrist, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD
    Lorraine and Alan Bressler Clinical and Research Program for Autism Spectrum Disorders, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Marie B. Gale Centennial Professor & Vice Chair
    Department of Psychiatry & Behavioral Sciences
    Director, Division of Child & Adolescent Psychiatry, University of Texas Medical Branch at Galveston
  • Director, Substance Abuse Services Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Director, Center for Addiction Medicine, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Director, Child and Adolescent Outpatient Department, Massachusetts General Hospital
    Director, Pediatric Bipolar Disorder Clinical and Research Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School

Accommodations

A limited number of rooms have been reserved at the Westin Copley Place at a discounted rate of $259 (plus state and local taxes) per night on a first-come, first served basis until February 19, 2014.

Click here to reserve a hotel room

To reserve by phone, call the Westin at (617) 262-9600 and specify that you are attending this conference.

CME Information

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

McLean Hospital designates this live activity for a maximum of 23.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Credit Designation

Psychologists: The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 23.50 Continuing Education (CE) credits for psychologists.

Nurses: This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 23.50 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation

Social Workers: This program has been approved for 23.5 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 61508.


Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.


Planner Disclosures

The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:
Tristan Gorrindo, MD; Reviewer
Jane Pimental

The following planners and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

Joseph Biederman, MD
In 2012, Dr. Joseph Biederman received an honorarium from the MGH Psychiatry Academy and The Children’s Hospital of Southwest Florida/Lee Memorial Health System for tuition-funded CME courses.

In 2011, Dr. Joseph Biederman gave a single unpaid talk for Juste Pharmaceutical Spain, received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course, and received honoraria for presenting at international scientific conference on ADHD. He also received an honorarium from Cambridge University Press for a chapter publication. Dr. Biederman received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Eli Lilly, Shire and AstraZeneca; these royalties are paid to the Department of Psychiatry at MGH.

In 2010, Dr. Joseph Biederman received a speaker’s fee from a single talk given at Fundación Dr.Manuel Camelo A.C. in Monterrey Mexico. Dr. Biederman provided single consultations for Shionogi Pharma Inc. and Cipher Pharmaceuticals Inc.; the honoraria for these consultations were paid to the Department of Psychiatry at the MGH. Dr. Biederman received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course.

In previous years, Dr. Joseph Biederman received research support, consultation fees, or speaker’s fees for/from the following additional sources: Abbott, Alza, AstraZeneca, Boston University, Bristol Myers Squibb, Celltech, Cephalon, Eli Lilly and Co., Esai, Fundacion Areces (Spain), Forest, Glaxo, Gliatech, Hastings Center, Janssen, McNeil, Medice Pharmaceuticals (Germany), Merck, MMC Pediatric, NARSAD, NIDA, New River, NICHD, NIMH, Novartis, Noven, Neurosearch, Organon, Otsuka, Pfizer, Pharmacia, Phase V Communications, Physicians Academy, The Prechter Foundation, Quantia Communications, Reed Exhibitions, Shire, the Spanish Child Psychiatry Association, The Stanley Foundation, UCB Pharma Inc., Veritas, and Wyeth.

Thomas J. Spencer, MD
Research Support:
Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, Pfizer, NIMH and the Department of Defense.
Speaking:
Shire Laboratories, Inc, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals.
Advisory Board:
Alcobra, Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, and Pfizer.

Dr. Spencer has a US Patent Application pending (Provisional Number 61/233,686), through MGH corporate licensing, on a method to prevent stimulant abuse.

Timothy E. Wilens, MD
Research Support:
Abbott, McNeil, Eli Lilly & Co., NIH (NIDA), Merck, and Shire.
Speaker/Honoraria:
McNeil, Eli Lilly & Co., Shire, and Novartis.
Advisory/Consulting:
Abbott, McNeil, Eli Lilly & Co., NIH (NIDA), Merck, Shire, and Novartis


Hardware/Software Specifications:

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements:
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


 

Your Registration is now complete. See you in Boston!

 

Location

10 Huntington Ave, The Westin Copley Place, Boston, Massachusetts, USA